Annual Cash & Cash Equivalents:
$127.98M-$63.46M(-33.15%)Summary
- As of today, STOK annual cash & cash equivalents is $127.98 million, with the most recent change of -$63.46 million (-33.15%) on December 31, 2024.
- During the last 3 years, STOK annual cash & cash equivalents has fallen by -$16.91 million (-11.67%).
- STOK annual cash & cash equivalents is now -55.45% below its all-time high of $287.31 million, reached on December 31, 2020.
Performance
STOK Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$248.31M+$527.00K(+0.21%)Summary
- As of today, STOK quarterly cash & cash equivalents is $248.31 million, with the most recent change of +$527.00 thousand (+0.21%) on September 30, 2025.
- Over the past year, STOK quarterly cash & cash equivalents has increased by +$9.04 million (+3.78%).
- STOK quarterly cash & cash equivalents is now -30.52% below its all-time high of $357.40 million, reached on March 31, 2025.
Performance
STOK Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
STOK Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -33.1% | +3.8% |
| 3Y3 Years | -11.7% | -1.3% |
| 5Y5 Years | -42.5% | +29.7% |
STOK Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -33.1% | +12.7% | -30.5% | +39.0% |
| 5Y | 5-Year | -55.5% | +12.7% | -30.5% | +39.0% |
| All-Time | All-Time | -55.5% | +7022.0% | -30.5% | +151.7% |
STOK Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $248.31M(+0.2%) |
| Jun 2025 | - | $247.78M(-30.7%) |
| Mar 2025 | - | $357.40M(+64.7%) |
| Dec 2024 | $127.98M(-33.1%) | $216.97M(-9.3%) |
| Sep 2024 | - | $239.28M(-15.2%) |
| Jun 2024 | - | $282.06M(+57.9%) |
| Mar 2024 | - | $178.58M(-11.3%) |
| Dec 2023 | $191.44M(+68.6%) | $201.39M(-6.2%) |
| Sep 2023 | - | $214.72M(-7.2%) |
| Jun 2023 | - | $231.45M(-8.8%) |
| Mar 2023 | - | $253.67M(+10.5%) |
| Dec 2022 | $113.56M | $229.59M(-8.8%) |
| Sep 2022 | - | $251.66M(-8.7%) |
| Jun 2022 | - | $275.63M(-6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $293.22M(+33.4%) |
| Dec 2021 | $144.90M(-49.6%) | $219.81M(-7.0%) |
| Sep 2021 | - | $236.30M(-6.0%) |
| Jun 2021 | - | $251.37M(-6.1%) |
| Mar 2021 | - | $267.66M(-6.8%) |
| Dec 2020 | $287.31M(+29.1%) | $287.31M(+50.1%) |
| Sep 2020 | - | $191.46M(-5.2%) |
| Jun 2020 | - | $201.93M(-4.4%) |
| Mar 2020 | - | $211.29M(-5.0%) |
| Dec 2019 | $222.47M(+111.1%) | $222.47M(-4.5%) |
| Sep 2019 | - | $233.05M(-4.0%) |
| Jun 2019 | - | $242.68M(+146.0%) |
| Mar 2019 | - | $98.65M(-6.4%) |
| Dec 2018 | $105.40M(+5765.3%) | $105.40M |
| Dec 2017 | $1.80M | - |
FAQ
- What is Stoke Therapeutics, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Stoke Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Stoke Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of STOK is $127.98M
What is the all-time high annual cash & cash equivalents for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high annual cash & cash equivalents is $287.31M
What is Stoke Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, STOK annual cash & cash equivalents has changed by -$63.46M (-33.15%)
What is Stoke Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of STOK is $248.31M
What is the all-time high quarterly cash & cash equivalents for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $357.40M
What is Stoke Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, STOK quarterly cash & cash equivalents has changed by +$9.04M (+3.78%)